Post‑Transplant, Aspergillus DNA, Qualitative RT PCR, Blood
Also known as: Specialized, Services, PTxplnt, Txplnt, Quest Advanced
Use
Diagnostic methods based on real‑time PCR provide rapid and specific detection of Aspergillus DNA from clinical specimens. This rapid detection is especially critical in post‑transplant patients, where early diagnosis of invasive aspergillosis can significantly affect treatment decisions and outcomes. Timely identification is essential for distinguishing A. terreus, which may be refractory to amphotericin B treatment.
Special Instructions
Not provided.
Limitations
Laboratory results must always be interpreted in conjunction with clinical observations. This test was developed by Quest Diagnostics and has not been cleared or approved by the U.S. Food and Drug Administration; the FDA has determined such clearance is not necessary. The laboratory is certified under CLIA as qualified to perform high‑complexity clinical testing. Reported reference range is "Not Detected."
Methodology
PCR-based (PCR)
Biomarkers
Result Turnaround Time
1 day
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided